Tebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product review

Tebentafusp (IMCgp100, Kimmtrak) is a first-in-class Immune mobilizing monoclonal T-cell receptors against cancer (ImmTAC). ImmTAC are fusion proteins comprising an affinity-enhanced soluble T-cell receptor (TCR) against a specific peptide-HLA complex and an anti-CD3 single-chain variable fragment (...

Полное описание

Библиографические подробности

Главные авторы:	Jonathan E. Cohen, Inderjit Mehmi, Mordechai Avner, Justin Moyers, Omid Hamid
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Taylor & Francis Group 2026-12-01
Серии:	Human Vaccines & Immunotherapeutics
Предметы:	Uveal melanoma cancer immunotherapy Immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) T-cell receptor (TCR) human leukocyte antigen (HLA)
Online-ссылка:	https://www.tandfonline.com/doi/10.1080/21645515.2026.2675068
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!